Clinical Trial Update: Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

View source ↗

Summary

Clinical trial evaluating cabozantinib in elderly patients with metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Renal Cell Carcinoma | Status: COMPLETED